Business Description
Glenmark Life Sciences Ltd
ISIN : INE03Q201024
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.58 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | 390.34 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 17.36 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.4 | |||||
3-Year EBITDA Growth Rate | 5 | |||||
3-Year EPS without NRI Growth Rate | 10.2 | |||||
3-Year FCF Growth Rate | -3.9 | |||||
3-Year Book Growth Rate | 45.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 13.91 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.86 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.03 | |||||
9-Day RSI | 29.66 | |||||
14-Day RSI | 38.84 | |||||
6-1 Month Momentum % | 31.44 | |||||
12-1 Month Momentum % | 63.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.37 | |||||
Quick Ratio | 2.85 | |||||
Cash Ratio | 0.69 | |||||
Days Inventory | 222.61 | |||||
Days Sales Outstanding | 131.91 | |||||
Days Payable | 135.51 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.18 | |||||
Dividend Payout Ratio | 0.62 | |||||
Forward Dividend Yield % | 4.22 | |||||
5-Year Yield-on-Cost % | 2.21 | |||||
Shareholder Yield % | 2.15 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.69 | |||||
Operating Margin % | 26.73 | |||||
Net Margin % | 20.36 | |||||
FCF Margin % | 12.96 | |||||
ROE % | 19.54 | |||||
ROA % | 15.76 | |||||
ROIC % | 21.51 | |||||
3-Year ROIIC % | 3.09 | |||||
ROC (Joel Greenblatt) % | 31.48 | |||||
ROCE % | 25.5 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 28.35 | |||||
Forward PE Ratio | 24.52 | |||||
PE Ratio without NRI | 28.35 | |||||
Price-to-Owner-Earnings | 39.84 | |||||
PEG Ratio | 2.75 | |||||
PS Ratio | 5.77 | |||||
PB Ratio | 5.42 | |||||
Price-to-Tangible-Book | 5.46 | |||||
Price-to-Free-Cash-Flow | 44.49 | |||||
Price-to-Operating-Cash-Flow | 30.61 | |||||
EV-to-EBIT | 20.56 | |||||
EV-to-EBITDA | 18.83 | |||||
EV-to-Revenue | 5.63 | |||||
EV-to-FCF | 43.43 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.61 | |||||
Price-to-Graham-Number | 2.55 | |||||
Price-to-Net-Current-Asset-Value | 9.04 | |||||
Earnings Yield (Greenblatt) % | 4.86 | |||||
FCF Yield % | 2.25 | |||||
Forward Rate of Return (Yacktman) % | 12.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Glenmark Life Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 21,949.36 | ||
EPS (TTM) (₹) | 36.4 | ||
Beta | 0.91 | ||
Volatility % | 38.47 | ||
14-Day RSI | 38.84 | ||
14-Day ATR (₹) | 60.816772 | ||
20-Day SMA (₹) | 1169.305 | ||
12-1 Month Momentum % | 63.85 | ||
52-Week Range (₹) | 608.55 - 1335 | ||
Shares Outstanding (Mil) | 122.53 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Glenmark Life Sciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Glenmark Life Sciences Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Glenmark Life Sciences Ltd Frequently Asked Questions
What is Glenmark Life Sciences Ltd(BOM:543322)'s stock price today?
When is next earnings date of Glenmark Life Sciences Ltd(BOM:543322)?
Does Glenmark Life Sciences Ltd(BOM:543322) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |